| 1.29 0.14 (12.17%) | 12-31 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.4 |
1-year : | 2.81 |
| Resists | First : | 2.05 |
Second : | 2.4 |
| Pivot price | 1.15 |
|||
| Supports | First : | 1 |
Second : | 0.34 |
| MAs | MA(5) : | 1.17 |
MA(20) : | 1.15 |
| MA(100) : | 0.83 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0  |
| %K %D | K(14,3) : | 57 |
D(3) : | 45 |
| RSI | RSI(14): 65.3 |
|||
| 52-week | High : | 3.84 | Low : | 0.28 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KTTA ] has closed above the upper band by 31.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 47.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.3 - 1.31 | 1.31 - 1.31 |
| Low: | 1.12 - 1.12 | 1.12 - 1.13 |
| Close: | 1.28 - 1.29 | 1.29 - 1.3 |
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Wed, 31 Dec 2025
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mon, 15 Dec 2025
Pasithea Therapeutics Regains Nasdaq Compliance - TipRanks
Wed, 03 Dec 2025
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Tue, 02 Dec 2025
Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock - GlobeNewswire
Mon, 01 Dec 2025
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com
Sat, 29 Nov 2025
Pasithea Therapeutics Stock Surges with New Public Offering and Promising Trial Results - timothysykes.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 22 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 1.5 (%) |
| Held by Institutions | 22.9 (%) |
| Shares Short | 3,860 (K) |
| Shares Short P.Month | 39 (K) |
| EPS | -4.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.63 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -53.8 % |
| Return on Equity (ttm) | -90 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.3 |
| PEG Ratio | 0 |
| Price to Book value | 0.78 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|